ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 105 filers reported holding ANTARES PHARMA INC in Q3 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $123,000 | +15.0% | 30,000 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $107,000 | -1.8% | 30,000 | 0.0% | 0.01% | -7.7% |
| Q3 2021 | $109,000 | -16.8% | 30,000 | 0.0% | 0.01% | -18.8% |
| Q2 2021 | $131,000 | +6.5% | 30,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $123,000 | +2.5% | 30,000 | 0.0% | 0.02% | -5.9% |
| Q4 2020 | $120,000 | +48.1% | 30,000 | 0.0% | 0.02% | +30.8% |
| Q3 2020 | $81,000 | -1.2% | 30,000 | 0.0% | 0.01% | -13.3% |
| Q2 2020 | $82,000 | +15.5% | 30,000 | 0.0% | 0.02% | +15.4% |
| Q1 2020 | $71,000 | -49.6% | 30,000 | 0.0% | 0.01% | -35.0% |
| Q4 2019 | $141,000 | +41.0% | 30,000 | 0.0% | 0.02% | +33.3% |
| Q3 2019 | $100,000 | +1.0% | 30,000 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $99,000 | +7.6% | 30,000 | 0.0% | 0.02% | +7.1% |
| Q1 2019 | $92,000 | +12.2% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $82,000 | -18.8% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $101,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |